Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart)

Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart)
approved in Japan 
BAGSVAERD DENMARK -- (Marketwire) -- 12/25/12 --  Company
announcement No 84 / 2012:
http://hugin.info/2013/R/1667087/541141.pdf 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
that: 
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and      
originality of the information contained therein. 
Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1667087] 
Novo Nordisk
T. Tlf. +45 44 44 88 88
F. Fax +45 44 44 49 05